Omnicuris Logo
FSSAI Restricts Ashwagandha Use to Roots and Extracts

FSSAI Restricts Ashwagandha Use to Roots and Extracts

Read More
Full Text
4 weeks back

The FSSAI recently issued a critical advisory regarding the inclusion of Withania somnifera in dietary products. This directive clarifies that manufacturers must prioritize Ashwagandha root extracts and roots in health supplements and nutraceuticals. Furthermore, the FSSAI emphasizes compliance with the 2016 regulations to ensure consumer safety across India.



Permitted Use of Ashwagandha Root Extracts


Only certain plant parts are safe for human consumption according to Schedule IV of the 2016 regulations. Specifically, the advisory permits only the roots and Ashwagandha root extracts for use in nutraceuticals and functional foods. However, these ingredients must still adhere to prescribed limits and quality standards. Consequently, manufacturers must verify their raw materials to meet these strict legal requirements.



Prohibitions on Ashwagandha Leaves


Recent reports indicated that some manufacturers were using Ashwagandha leaves or leaf extracts in their products. Consequently, the FSSAI explicitly stated that the use of leaves in any form is currently not permitted. This decision aligns with previous directives from the Ministry of Ayush, which also limited product formulations to roots. Therefore, any product containing leaf-based ingredients is now considered non-compliant under the Food Safety and Standards Act of 2006.



Compliance and Enforcement


Food Business Operators (FBOs) must ensure their products align with these updated guidelines immediately. Furthermore, licensing authorities and food safety officers are now under instructions to maintain strict vigilance. Any observed deviation from these standards will lead to legal action. As a result, businesses should review their formulations to avoid penalties and ensure public health safety.



Frequently Asked Questions


Q1: Which parts of Ashwagandha are allowed in food products?


Only the roots and Ashwagandha root extracts are permitted under current FSSAI regulations for health supplements and nutraceuticals.


Q2: Why are Ashwagandha leaves prohibited?


The FSSAI and Ministry of Ayush have not authorized the use of leaves in food products, focusing on the historical and safety data associated with the roots.



Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.



References



  1. FSSAI issues advisory on Ashwagandha use in food products; permits only rootsand extract - ETHealthworld

  2. Food Safety and Standards (Health Supplements, Nutraceuticals, Food for Special Dietary Use, Food for Special Medical Purpose, Functional Food and Novel Food) Regulations, 2016.

  3. Ministry of Ayush Advisory on Withania somnifera (Ashwagandha) leaves.

Login to continue

More from MedShots Daily

FSSAI Restricts Ashwagandha Use to Roots and Extracts
FSSAI Restricts Ashwagandha Use to Roots and Extracts

FSSAI issues an advisory restricting Ashwagandha use in food products to roots and extracts only, prohibiting the use of leaves due to safety regulations....

4 weeks back

Read More
Full Text
Escalating Cancer Mortality in ILD Patients: A 21-Year Population Study
Escalating Cancer Mortality in ILD Patients: A 21-Year Population Study

A comprehensive analysis of over 500,000 cases shows that cancer-related deaths are rising in ILD patients, contradicting general national trends....

Today

Read More
Full Text
Bridging Gaps in the Perinatal SUD Continuum: From Screening to Treatment Engagement
Bridging Gaps in the Perinatal SUD Continuum: From Screening to Treatment Engagement

New research shows a critical disconnect in the perinatal SUD continuum, where screening rarely leads to treatment without proactive provider-led conversati...

Today

Read More
Full Text
Preoperative Anemia and Iron Deficiency in Cardiac Surgery: Diagnosis and Impact
Preoperative Anemia and Iron Deficiency in Cardiac Surgery: Diagnosis and Impact

A summary of the Inter-American Society of Cardiology position statement on diagnosing preoperative anemia and iron deficiency in cardiac surgery patients....

Today

Read More
Full Text
Virtual Walking Boosts Gait and Balance in Spinal Cord Injury
Virtual Walking Boosts Gait and Balance in Spinal Cord Injury

A study shows that virtual walking combined with physical exercise markedly improves walking speed and balance in people with chronic incomplete spinal cord...

Today

Read More
Full Text
Defining Remission in Long-Term Conditions Using EHR Data
Defining Remission in Long-Term Conditions Using EHR Data

A scoping review of 91 studies explores how Electronic Health Records (EHRs) define remission across 12 long-term conditions, emphasizing standardization....

Today

Read More
Full Text
Showing Page 1 of 1(5 items total)
Go to Page

"Wherever the art of Medicine is loved, there is also a love of Humanity."

— Hippocrates

made with❤️byOmnicuris